Log In
Print this Print this

TNFcept, Biosimilar etanercept

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionBiosimilar of etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Biosimilar
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today